siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 314 (1) , 283-291
- https://doi.org/10.1016/j.bbrc.2003.12.098
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- National Institutes of Health (NS35155)
- ALS Association
- Ministry of Education, Culture, Sports, Science and Technology (A-130)
This publication has 23 references indexed in Scilit:
- U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cellsNature Biotechnology, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysateThe EMBO Journal, 2001
- RNA interference—2001Genes & Development, 2001
- Control of the Functional Activity of an Antisense RNA by a Tetracycline-Responsive Derivative of the Human U6 snRNA PromoterHuman Gene Therapy, 2000
- From Charcot to SOD1Neuron, 1999
- Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosomeChemistry & Biology, 1999
- Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injuryNature Genetics, 1996
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993